Logo of ploscompComputational BiologyView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS Comput Biol. Sep 2007; 3(9): e173.
Published online Sep 14, 2007. doi:  10.1371/journal.pcbi.0030173
PMCID: PMC1976335

Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils

Eugene I Shakhovich, Editor

Abstract

Increasing evidence indicates that oligomeric protein assemblies may represent the molecular species responsible for cytotoxicity in a range of neurological disorders including Alzheimer and Parkinson diseases. We use all-atom computer simulations to reveal that the process of oligomerization can be divided into two steps. The first is characterised by a hydrophobic coalescence resulting in the formation of molten oligomers in which hydrophobic residues are sequestered away from the solvent. In the second step, the oligomers undergo a process of reorganisation driven by interchain hydrogen bonding interactions that induce the formation of β sheet rich assemblies in which hydrophobic groups can become exposed. Our results show that the process of aggregation into either ordered or amorphous species is largely determined by a competition between the hydrophobicity of the amino acid sequence and the tendency of polypeptide chains to form arrays of hydrogen bonds. We discuss how the increase in solvent-exposed hydrophobic surface resulting from such a competition offers an explanation for recent observations concerning the cytotoxicity of oligomeric species formed prior to mature amyloid fibrils.

Author Summary

Several peptides and proteins have been shown to convert from their soluble forms into highly ordered fibrillar aggregates, known as amyloid fibrils. It has also been realised that the formation of amyloid fibrils is often preceded by the appearance of small but highly organised oligomeric assemblies. Interest in these low molecular weight oligomers has increased considerably since these molecular species have been detected in the brains of patients suffering from Alzheimer disease. Evidence is accumulating concerning the ability of the low molecular weight oligomers formed by the Aβ peptide to specifically disrupt cognitive function. To increase our understanding of this phenomenon, we describe in this paper the early stages of the oligomerization process of two fragments (Aβ16–22 and Aβ25–35) of the Aβ peptide, by exploiting the possibility provided by computer simulations to describe aggregation reactions at the molecular level. Our results suggest that the ability of many diverse peptides and proteins to form amyloid fibrils, as well as the inherent toxicity of many oligomeric assemblies, are a consequence of the tendency of the backbone of polypeptide chains to form hydrogen bonds, and of the outcome of the competition between hydrophobic and hydrogen bonding forces.

Introduction

The phenomenon of protein aggregation is associated with a variety of human disorders [13], which include Alzheimer and Parkinson diseases, type II diabetes, and the spongiform encephalopathies, that are rapidly becoming a major challenge in terms of their social and economic impact on society. In addition, there is increasing evidence that the formation of ordered aggregates, known as amyloid fibrils, is not just an unusual characteristic of the 20 or so proteins associated with disease, but rather is just one of the possible conformations that any polypeptide chain can adopt under appropriate conditions [46]. Questions of great scientific and medical interest in this context include the molecular basis of amyloid formation and the nature of the toxic species that appear to be associated with amyloid formation in vivo and to result in pathogenic cell death in at least some of these diseases [6].

Experimental studies have shown for a range of peptides and proteins that amyloid fibril formation is preceded by the appearance of organised molecular assemblies usually termed protofibrils [711]. In addition, detailed biophysical studies are beginning to identify the formation of smaller oligomeric species at yet earlier stages of the aggregation process [12,13]. These oligomers appear initially to be relatively disordered, but then to convert into species containing extensive β sheet structure [10] that are often capable of stimulating fibril formation [14]. Interest in these low molecular weight oligomers has increased since these species have been detected in the brains of patients suffering from Alzheimer disease [15,16]. Although the identification of the species giving rise to neurodegeneration is one of the most controversial topics in current studies of misfolding diseases, evidence is accumulating concerning the ability of the low molecular weight oligomers of the Aβ peptide specifically to disrupt cognitive function [1721].

Even if highly complex processes are associated with oligomer toxicity, a view is gaining support according to which the ability to form toxic oligomeric species represents an intrinsic property of polypeptide chains at some stage of their oligomerization process [2226]. In addition, a link has been made recently between the toxicity and the hydrophobicity of polypeptide chains [2729]. Despite this growing interest in the role of peptide and protein oligomers in disease, the molecular mechanism by which they are formed remains to be fully elucidated. According to the “nucleated conformational conversion” (NCC) model for aggregate formation [14], a group of monomers initially present in solution coalesces to form “molten” oligomers, which subsequently undergo a reorganisation process and eventually give rise to more highly organised oligomers and fibrils rich in β sheet structure.

Although the nucleated conformational conversion mechanism has been supported by many experimental and theoretical observations [11,14,3034], a detailed description of this process at the molecular level remains in large part elusive because it is challenging to describe the early stages of aggregation of polypeptide chains by experiment, primarily because of the difficulties in detecting and characterising the small, structurally heterogeneous, and transient species that are involved.

The mechanism by which structured oligomers might grow upon addition of unstructured monomers has, however, been explored in a variety of computer simulations [34,35]. One particular type of mechanism, usually called dock and lock, was initially proposed by Esler et al. [36] to explain the experimental observation of the growth of Aβ fibrils. According to this idea, the attachment of a monomer to a preformed ordered oligomer or fibril is followed by a much slower and rate-limiting lock phase. Recent simulations [35] suggest that in this latter step the preformed oligomer undergoes a series of conformational fluctuations in order to accommodate the new peptide molecule.

In this paper we investigate the early stages of the oligomerization process for two fragments (Aβ16–22 and Aβ25–35) of the Aβ peptide, a key pathogenic agent in Alzheimer disease [21] by using all-atom computer simulations (see Methods) able to describe the essence of peptide aggregation reactions at the molecular level [3335, 3748].

Our results suggest that amyloid fibril formation is a generic property of protein aggregation [46] as a consequence of the fact that the ability of the main chain to form hydrogen bonds is common to all polypeptide chains and that the competition between hydrophobicity and hydrogen bonding is a major determinant of the aggregation process. They also suggest that the mechanism of aggregation that leads to the structural reorganisation involved in the growth of ordered oligomeric species could be a key determinant of their toxic properties.

Results

Simulations and Their Analysis

To study in detail the formation of large oligomers, we carried out two series of 100 independent all-atom simulations using the ProFASi (Protein Folding and Aggregation Simulator) program [4953] (see Methods) for systems of 20 peptides for each of the two fragments, Aβ16–22 (KLVFFAE) and Aβ25–35 (GSNKGAIIGLM).

Under the conditions that we used here, the peptides were observed to interact strongly with each other and to form oligomers (Figure 1), which are described as an assembly of Nc strongly interacting peptides. Peptides are considered to be interacting when the sum of their interchain hydrogen bonds and hydrophobic interactions is greater than a cutoff value of 1.5 in model units, which corresponds approximately to the formation of two hydrogen bonds. According to this definition, oligomers may be found in many different conformations ranging from disorganised molten assemblies to well-ordered arrays of molecules rich in β sheet structure.

Figure 1
Representative Conformations in a Monte Carlo Simulation

To follow their assembly process in more detail, we further distinguish between ordered β sheet rich regions and disordered amorphous ones by introducing a local-order parameter β that is calculated at the individual residue level and then averaged over the entire ensemble of 20 peptides (see Methods). If all residues of all peptides are in a β sheet configuration, β = 1, and if no residues of any molecule are in such structure, β = 0. To probe the early stages of the process associated with the formation and growth of low molecular weight oligomers, we also measure the time evolution of properties of single oligomers, rather than of the ensemble of all peptides. For this reason, we define a local-order parameter βo, which is averaged only over the peptides that are contained in one specific oligomer.

To focus on the assembly and structural formation of these oligomers that are likely to involve substantial transitions as the size of oligomers increases, we analysed a range of temperatures and concentrations to identify the appropriate conditions (see Methods). On the basis of these studies, we chose to study the aggregation of both Aβ16–22 and Aβ25–35 inside a cubic box with periodic boundary conditions of (60 Å)3 and a temperature of 295 K.

Time Evolution of the Populations of Oligomers

Under the conditions used in this study, the aggregation process of the Aβ16–22 peptide proceeds without crossing major free energy barriers, so that the lag phase, which is often observed in experimental studies of amyloid formation [6], is suppressed and oligomers start forming immediately without the need for a nucleation event. Thus, from an initial configuration of monomers, we observe the rapid formation of oligomers. These oligomers are themselves transient species and undergo a process of internal reorganisation that can take them through a succession of increasingly ordered states. To analyze the trajectories in a non-equilibrium regime, we divide them into a series of time windows (Figures 2 and and3).3). We plot the populations P of oligomers of given sizes (Nc = 5, 11, and 14 for Aβ16–22 in Figure 2, and Nc = 5, 8, and 10 for Aβ25–35 in Figure 3) as a function of their degree of local order, βo.

Figure 2
Time Dependence of the Population of Aβ16–22 Oligomers
Figure 3
Time Dependence of the Population of Aβ25–35 Oligomers

We observe clear time dependencies both of the oligomer populations and of their degrees of order. For small oligomers (Nc = 5), the data show a decrease in the populations of the disordered species with time. In larger ones, the time evolution is more complicated and so we describe the behavior of the two peptides, Aβ16–22 and Aβ25–35, separately. For Aβ16–22, the population of large oligomers (Nc = 14, Figure 2) does not vary significantly with time but the peak of the βo distribution shifts toward a higher degree of order. This peptide can therefore be seen to form large disordered oligomers very quickly, which then reorganize and form species with a high content of β sheet structure. Such a mechanism has been described by Serio et al. [14] in order to interpret experimental results for a yeast prion, and experimental evidence that this type of behavior may be general has been reported by Plakoutsi et al. [30], Bader et al. [11] and Petty and Decatur [31]. In the simulations of the Aβ25–35 peptide, however, a different scenario emerges as the number of large, predominantly ordered, oligomers (Nc = 10, Figure 3) increases with time. These differences between the time-dependent evolution of large oligomers of Aβ16–22 and Aβ25–35 indicate an underlying diversity in the fundamental mechanisms of self-assembly, which is analyzed in greater detail in the next section.

Since the analysis of the different populations reveals that oligomers of different sizes undergo a process of reorganisation on different time scales, and hence achieve different degrees of structural order at similar times, it becomes evident that a simple ensemble average, as shown in Figure S1, is not an optimal method of describing the process of aggregation. It is not possible from an ensemble average over the 100 independent simulations to follow the nature of the structural transitions of the oligomers from an analysis of the total hydrogen bond energy, hydrophobic interactions, and β sheet content as a function of time. We observed, however, that the average β sheet content increases over time throughout our simulations, and we, therefore, monitor the average hydrogen bonding and hydrophobic energy for each value of the degree of order β (Figures 4 and and55).

Figure 4
Coalescence and Reorganisation of Aβ16–22
Figure 5
One-Step Ordering of Aβ25–35 Oligomers

Coalescence and Reorganisation of Aβ16–22

The pathway followed by the Aβ16–22 peptides during the process of oligomerization can be divided into two steps. In the first, the monomers present at the beginning of the simulation coalesce rapidly into molten oligomers as a result of strong interactions between hydrophobic residues. The evidence for such a coalescence and its hydrophobic nature is shown in Figure 2, where a population of large oligomers (Nc = 14) is present very early in the simulations, and in Figure 4B, where the initial disordered structures can be seen to be stabilised by strong hydrophobic interactions, as in these early structures the majority of the hydrophobic residues (gray spheres) are buried within the coalesced configurations to form oligomers with very few hydrogen bonding interactions (Figure 4A).

These oligomers are substantially disordered as the largely nondirectional hydrophobic interactions form rapidly while the hydrogen bonding interactions have a strong distance and angular dependence and therefore form more slowly. In the second step of the assembly process, these collapsed oligomers undergo a process of reorganisation (Figure 2) as revealed by a time-dependent shift toward higher values of the order parameter. This ordering process is driven by the formation of directional interchain hydrogen bonds between the peptides (Figure 4A), which transform the molten oligomers produced by the initial hydrophobic collapse, in which no significant secondary structure is present, into oligomers rich in β sheet structure. As a consequence of this process, many of the hydrophobic residues that are initially buried inside the oligomer become exposed to the solvent (Figure 4B), with a consequent decrease in the contribution of the hydrophobic interactions to the stability of the oligomers. In Figure 6D we show how the population of oligomers and of β sheet structures depends on the sizes of the oligomers and the extent of β sheet structure within them, under the conditions of temperature and concentration used throughout this study. As a consequence of the initial hydrophobic collapse and the subsequent conformational conversion, the two distributions appear very different. This type of reorganisation has been characterised experimentally by Petty and Decatur [31] using isotope-edited infrared spectroscopy and described theoretically as a “reptation” process by Santini et al. [47] using an activation–relaxation computational technique (ART) and by Nguyen et al. [35] with the dock and lock mechanism.

Figure 6
Populations of Oligomers and β Sheets

Direct Ordering of Aβ25–35 Oligomers

25–35 is significantly less hydrophobic than Aβ16–22. As a consequence of this fact, there is no significant hydrophobic coalescence of molecules leading to the formation of disordered oligomers. Instead, the incorporation of a molecule into an ordered β sheet takes place in a single step, driven by the formation of the interchain hydrogen bonds (Figure 5), such that the oligomers of Aβ25–35 grow in a highly ordered fashion. Particularly clear evidence for this type of growth is provided by the data reported in Figure 3, where, even in the first time window, small Aβ25–35 oligomers (Nc = 5) are seen to have a relatively high degree of order and to be highly populated, while the number of larger oligomers (Nc = 10) increase significantly more slowly. This behavior is strikingly different from that of Aβ16–22 shown in Figure 2, where a substantial population of large oligomers is formed early but the latter become ordered more slowly than do the large oligomers of the Aβ25–35 peptide.

This distinction is also seen from the differences in the nature of the populations of oligomers and β sheets in the simulations of the two peptides. For Aβ25–35, as shown in Figure 6E, the two population distributions are almost identical, indicating clearly that the oligomers do indeed grow in an ordered fashion. A further consequence of the differences in the aggregation processes of the two peptides can be seen in Figure 7, where the populations of oligomers are described as a function of the β sheets present within them. The hydrophobic coalescence observed in the formation of oligomers of the Aβ16–22 fragment produces complex structures containing several small segments of β sheet, while the more hydrogen bond driven oligomerization of the Aβ25–35 fragment results in simple oligomers with a small number of extended β sheet structures.

Figure 7
Populations of Oligomers as a Function of the Total Number of β Sheets Contained within the Oligomers

In addition, the data shown in the last time window in Figure 3 reveal that the distribution of large Aβ25–35 oligomers reaches a maximum at high values of the order parameter βo, while the number of smaller oligomers is effectively the same for a large range of βo values. In other words, the degree of order of a β sheet increases with its size, a finding that is consistent with the extremely high degree of long-range order found in amyloid fibrils [6,35]. In agreement with our findings, recent studies [54] of a variety of truncated peptides of Aβ40/42, the fragment 25–35 of the Aβ peptide was found to form β sheet rich structures more readily than the fragment 17–21. The latter peptide was found, however, to generate much greater toxicity in cellular aggregates than the corresponding fragment 25–35.

Exposure of Hydrophobic Residues in the Oligomer Species

A series of recent studies has suggested that the toxicity of amyloid aggregates depends on their size [22,25,26], with the maximum toxicity corresponding to those species with amyloid characteristics that have the highest surface-to-volume ratio. In addition, there is increasing evidence of a relationship between the hydrophobicity of the polypeptide chains and the toxicity of the oligomers that they form [2729]. These results are consistent with the idea that toxicity could result from aberrant interactions with cellular components such as membranes, proteasomes, or molecular chaperones [22,55,56]. Such interactions are likely to be caused by the extended solvent-exposed hydrophobic surfaces exhibited by these oligomers, as probed, for example, by ANS binding experiments [57,58].

Recent experiments [54] have suggested that residues 17–21 play a key role in the toxicity of the Aβ40 and Aβ42 peptides. We therefore studied the time evolution of the solvent-exposed hydrophobic surface of Aβ16–22 during the formation of β rich oligomeric assemblies. We exploited the all-atom representation of the Aβ16–22 peptides in our simulations to calculate the total number of solvent-exposed hydrophobic residues in the entire ensemble and also the average number per molecule in oligomers of specific sizes (i.e., STOT and S, respectively, see Methods). Our results show that the nature of the solvent-exposed surface is primarily determined by two competing processes. First, the initially formed collapsed oligomers undergo a conformational transition into β sheet rich structures and expose an increasing number of hydrophobic residues (Figure 4B). Second, the oligomers grow into larger species and their surface-to-volume ratio decreases. The net effect is illustrated in Figure 8, where, as an example, we show two oligomeric configurations with the same relative β sheet content (βo); smaller oligomers have weaker total hydrophobic interactions and therefore have a larger fraction of exposed hydrophobic residues. These two processes, along with the initial hydrophobic collapse, contribute to Sn(τ) in Equation 4.

Figure 8
Surface-to-Volume Dependence for the Exposure of Hydrophobic Residues in Oligomeric Species

To describe the process over the whole ensemble of oligomers (STOT(τ)), however, we need to consider also the distribution of aggregates of different sizes (Equation 3). The result is that the overall number of exposed hydrophobic residues (Figure 9) initially grows due to the increased exposure resulting from the reorganisation of the initially formed oligomers and later decreases due to the combined effect of the decreasing surface-to-volume ratio as the oligomers grow in size and the consequent reduction in the total number of oligomers. Remarkably, this behaviour is at least qualitatively very similar to that of the toxicity reported by Bucciantini et al. [22,26], suggesting that the extent to which hydrophobic residues are exposed could well be a crucial factor in determining the toxic properties of oligomers during the formation of amyloid fibrils and plaques.

Figure 9
Time Dependence of the Total Exposed Hydrophobic Area in the Oligomeric Ensemble

Discussion

The analysis of the conversion of monomeric Aβ16–22 and Aβ25–35 peptides into oligomers, observed using computer simulations, suggests that this process occurs by a generic “two-step” mechanism and that it is highly dependent on their degree of hydrophobicity. The more hydrophobic Aβ16–22 peptides initially coalesce into disordered oligomers that subsequently undergo a process of conformational conversion that leads to the formation of highly ordered species. By contrast, the hydrophobicity of the Aβ25–35 peptides is not sufficient to drive an initial coalescence step, and the peptides instead form ordered aggregates effectively in a single step driven by the formation of hydrogen bonds (Figure 10). This process can be considered to be a special case of the two-step mechanism in which its first step is effectively suppressed.

Figure 10
Schematic Diagram of the Two-Step Mechanism of Amyloid Formation

These results suggest that interchain hydrophobic interactions and the specific sequence of a polypeptide chain are likely to play a major role in promoting the formation of oligomeric species. Indeed, experiments suggest that concentration, temperature, and hydrophobicity all influence the rate of collapse of a given polypeptide chain into different types of aggregates [11]. If the rate of collapse is fast compared with that of conformational conversion, aggregation will take place by a process of coalescence and reorganisation. By contrast, if hydrophobic forces are less important in driving the association of peptide molecules, ordered oligomers essentially assemble directly.

The two-step process that describes amyloid formation is therefore modulated by the competition between hydrogen bonding and hydrophobicity. While the initial coalescence step is driven primarily by the rapid formation of relatively nonspecific hydrophobic interactions, the conformational conversion that results in the formation of ordered β sheet structures is predominantly a consequence of the slow formation of highly directional interchain hydrogen bonds. The fact that this process of conformational conversion has been found both experimentally and theoretically in a range of other studies of a variety of models systems [11,14,30,31,33,35] suggests that this process could indeed be a generic one. Importantly, a mechanism of this type is consistent with the hypothesis that the ability to form fibrils is a common property of polypeptide chains and that the resulting structures have similar structural characteristics regardless of the peptides or proteins involved [46]. Experimental evidence for the importance of the competition between hydrogen bonding and hydrophobic interactions in the aggregation process has been found in studies in which changes in the solution conditions that result in a change in the hydrogen bonding interactions led either to fibrillar or nonfibrillar aggregates with similar β sheet content but with distinct morphological features [59].

The results that we have presented in this article provide a detailed description of a process in which the formation of intermolecular hydrogen bonds is at the origin of the generation of β sheets within oligomeric species [31]. By extension, the sequence-independent nature of the hydrogen bonding interactions in oligomers observed in the present study can also rationalize the observation of the inherent toxicity of species formed prior to the mature fibrils. This latter observation has been demonstrated for both disease- and nondisease-related peptides and proteins [22,24,26].

We have also found in the present study that the conformational conversion that results in ordered oligomers also leads to an increase in the number of hydrophobic residues that are exposed to the solvent. This process, however, is offset by the decrease in the surface-to-volume ratio of oligomers as their size increases with time. A combination of these two effects gives rise to the prediction that there will be a maximum in the dependence of toxicity, a phenomenon likely to be related to exposed hydrophobic residues, on aggregate size, and hence on the time over which aggregation occurs. Such a maximum has been observed in experimental studies of the effects of aggregates on the viability of cells in culture and indeed within the brains of higher organisms [22,26]. Our results suggest that the competition between hydrogen bonding and hydrophobic interactions is the crucial factor that modulates the subtle balance between the generic ability and relative propensities of polypeptide molecules to form ordered structures and the potential toxicity of the resulting species to living systems.

Methods

Model.

Simulations were carried out with ProFASi [53], which implements an implicit water all-atom model [4952] for protein folding and aggregation studies. The model assumes fixed bond lengths, bond angles, and peptide torsional angles, so that each amino acid has only the Ramachandran torsional angles and the side chains torsional angles as its degrees of freedom. The interaction potential

equation image

is composed of four terms. The Eloc term is local and represents an electrostatic interaction between adjacent peptides along the chain and the Eev term is a 1/r12 repulsion between pairs of atoms. The hydrogen bonding contributions to the energy are calculated by a term, Ehb, in which the distance dependence is modeled through a Lennard-Jones potential between pairs of NH and CO groups within a given cutoff of 4.5 Å, and the angular dependence is expressed as a function of the NH···O and H···OC angles [52]. The hydrophobicity term Ehp is defined by a contact potential between hydrophobic side chains, the latter being proportional to the fraction of atoms in contact in the two amino acids [52]. The parameters of the potential were chosen by optimizing the agreement with the melting temperature of the Trp-cage miniprotein; the resulting force field has been shown to reproduce accurately the folded states and the melting temperatures of a range of polypeptide chains of both α and β structures, including Betanova, GB1p, LLM, and Fs, with excellent agreement with both CD and NMR data [52]. In addition, properties such as the content of α-helix and the relative population of folded species was also found to be in excellent agreement with experimental data [52]. ProFASi has also already been applied to study the aggregation of a series of short peptides, including the Aβ16–22 fragment considered here [50]. Those simulations generated a series of conformations of the assemblies of the Aβ16–22 peptide containing in register the antiparallel structures, a behaviour previously observed experimentally [60]. The Monte Carlo simulations that we describe in this work were performed at constant temperature in a periodic box of 60 Å using only local updates [61] and rigid body translations and rotations. In Figure 6 we compare the oligomer population and the β sheet population for several such cases. We tested simulations in a cubic box of (130 Å)3 at 295, 335, and 370 K and in a cubic box of (60 Å)3 at 295 and 330 K. In some cases (Figure 6A and and6C),6C), we do not observe a complete collapse of all the peptides, and in other cases (Figure 6B) the population of oligomers is essentially the same as the β sheet contour. In some systems, see Figure 6F, the oligomer population is artificially skewed toward very large oligomers as a consequence of the finite size of the system. On the basis of these studies, we chose to study the aggregation of both Aβ16–22 (Figure 6D) and Aβ25–35 (Figure 6E) inside a cubic box with periodic boundary conditions of (60 Å)3 and at a temperature of 295 K. We then analysed ensembles of trajectories to identify the major kinetic events during the aggregation process. This type of analysis is based on the observation that if kinetic events are separated by a large number of local moves and are observed in an ensemble of trajectories, they represent significant shifts in population distribution and reflect properties of the free energy landscape such as the depth of local minima and the height of the barriers between them [62].

The local-order parameter.

To be able to describe the ordering process at the level of individual residues, we introduce the concept of “local order” using the parameter βij for i-th residue in the j-th peptide. To identify the local order (βij) of each residue, we follow the procedure of the local-structure vector, ql(i,j), used by ten Wolde et al. and Auer et al. [63,64], where l is the index of the spherical harmonics used to determine the symmetry of local structure near atom i. We calculate this vector only for the Cα atoms in each residue. A clear distinction between ordered and disordered residues can conveniently be made by using l = 4, since every residue in a β sheet has an approximate fourfold symmetry. The vector q4(i,j), therefore, reveals the geometrical structure in the vicinity of residue i in peptide j.

A high correlation between these vectors calculated over two nearby atoms i and i′ (less than 5.5 Å apart) implies that they have similar local environments [63]. If we find at least three other residues with similar local environments in the vicinity of residue i, we define the residue to be ordered and set βij = 1, otherwise we define it to be disordered and βij = 0. In Figure 11 we calculate the average of the residue-specific local order (βij) over the whole ensemble of peptides (β) and over the peptides contained in a single specific oligomer (βo).

Figure 11
Example of Calculation of the Residue-Specific Local Order

Measurement of the hydrophobic surface of the oligomers.

By analyzing the results of our simulations, we concluded that the assembly of peptides is described by a Poisson process in which the elementary event consists in the attachment of an oligomer of, on average, 2.2 peptide molecules:

equation image

The time (τ) is scaled as τ = tα, where α is evaluated from the stretched exponential form of the autocorrelation function of the oligomers. The time dependence of the solvent accessible hydrophobic surface area is calculated as:

equation image

where Npep is the number of peptides in a system and Pn(τ) is the distribution of the oligomers as in Equation 2. The solvent-exposed hydrophobic surface area per oligomer is expressed as:

equation image

The first term of Sn(τ) represents the coalescence step that typically is driven by the burial of hydrophobic side chains. The second term is the ordering process by which hydrophobic side chains can become exposed. As Nc is proportional to the volume of the oligomer, the term An external file that holds a picture, illustration, etc.
Object name is pcbi.0030173.ex001.jpg represents their surface-to-volume ratio.

The molecular simulations that we have performed enable the parameters A1, A2, k1 , λ, and k2 to be estimated, thus providing a general expression for Sn and Pn for oligomers of any size. We estimated k2 = 0.0134, from the ordering of β content in time, and λ = 0.5 by fitting the probability distribution of the oligomers. Values for the other three parameters A1 = 3.2, A2 = 9.3, k1 = 0.207 were obtained from the hydrophobic energy per peptide of oligomers in time.

We use this equation to plot the hydrophobic surface area in Figure 9 for a system of Npep = 5,000 peptide molecules. The peak time τ = 140 corresponds to 4 × 1013 Monte Carlo steps.

Supporting Information

Figure S1

Time Dependence of the Hydrogen Bond and Hydrophobic Energy and of the β Sheet Content:

Hydrogen Bond (A), Hydrophobicity (B), and β Sheet Content as a function of time. These quantities are different from the ones shown in Figures 4 and and5.5. These quantities are calculated as an ensemble average over the 100 independent simulations, while in Figures 4 and and55 the averages are calculated over the ensemble of configurations with the same degree of β sheet content (β). The striking difference between the two behaviours is due to the different time scales of the process of conformational conversion for oligomers of different sizes as shown in Figures 4 and and55.

(958 KB TIF)

Acknowledgments

Our work has been supported by the Korea Research Foundation, grant KRF-2005–214-C00049 (MC), the National Research Laboratory Program of the Ministry of Science and Technology, Korea, M1-0203-000029 (MC and IC), the Wellcome Trust (CMD), the Royal Society (MV), the Leverhulme Trust (CMD, MV, and GF), and the Engineering and Physical Sciences Research Council (EPSRC) (GF).

Abbreviations

ProFASi
Protein Folding and Aggregation Simulator

Footnotes

Author contributions. CMD, MV, and GF conceived and designed the experiments. MC performed the experiments. MC and GF analyzed the data. IC and SM contributed reagents/materials/analysis tools. MC, LML, CMD, MV, and GF wrote the paper.

Funding. The authors received no specific funding for this study.

Competing interests. The authors have declared that no competing interests exist.

References

  • Selkoe DJ. Folding proteins in fatal ways. Nature. 2003;426:900–904. doi: 10.1038/nature02264. Available: http://dx.doi.org/10.1038/nature02264. Accessed 8 August 2007. [PubMed]
  • Roberson ED, Mucke L. 100 years and counting: Prospects for defeating Alzheimer disease. Science. 2006;314:781–784. doi: 10.1126/science.1132813. http://dx.doi.org/10.1126/science.1132813. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Lansbury PT, Lashuel HA. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature. 2006;443:774–779. doi: 10.1038/nature05290. Available: http://dx.doi.org/10.1038/nature05290. Accessed 8 August 2007. [PubMed]
  • Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci. 1999;24:329–332. [PubMed]
  • Dobson CM. Protein folding and misfolding. Nature. 2003;426:884–890. doi: 10.1038/nature02261. Available: http://dx.doi.org/10.1038/nature02261. Accessed 8 August 2007. [PubMed]
  • Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–366. doi: 10.1146/annurev.biochem.75.101304.123901. Available: http://dx.doi.org/10.1146/annurev.biochem.75.101304.123901. Accessed 8 August 2007. [PubMed]
  • Harper JD, Wong SS, Lieber CM, Lansbury PT. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol. 1997;4:119–125. [PubMed]
  • Harper JD, Lieber CM, Lansbury PT. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol. 1997;4:951–959. [PubMed]
  • Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem. 1997;272:22364–22372. [PubMed]
  • Calamai M, Canale C, Relini A, Stefani M, Chiti F, et al. Reversal of protein aggregation provides evidence for multiple aggregated states. J Mol Biol. 2005;346:603–616. doi: 10.1016/j.jmb.2004.11.067. Available: http://dx.doi.org/10.1016/j.jmb.2004.11.067. Accessed 8 August 2007. [PubMed]
  • Bader R, Bamford R, Zurdo J, Luisi BF, Dobson CM. Probing the mechanism of amyloidogenesis through a tandem repeat of the pi3-sh3 domain suggests a generic model for protein aggregation and fibril formation. J Mol Biol. 2006;356:189–208. doi: 10.1016/j.jmb.2005.11.034. Available: http://dx.doi.org/10.1016/j.jmb.2005.11.034. Accessed 8 August 2007. [PubMed]
  • Bitan G, Lomakin A, Teplow DB. Amyloid beta-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem. 2001;276:35176–35184. doi: 10.1074/jbc.M102223200. Available: http://dx.doi.org/10.1074/jbc.M102223200. Accessed 8 August 2007. [PubMed]
  • Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, et al. Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A. 2003;100:330–335. doi: 10.1073/pnas.222681699. http://dx.doi.org/10.1073/pnas.222681699. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science. 2000;289:1317–1321. [PubMed]
  • Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, et al. Morphology and toxicity of Abeta-(1–42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem. 1996;271:20631–20635. [PubMed]
  • Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol. 1999;155:853–862. [PMC free article] [PubMed]
  • Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535–539. doi: 10.1038/416535a. Available: http://dx.doi.org/10.1038/416535a. Accessed 8 August 2007. [PubMed]
  • Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloid-beta oligomers: Their production, toxicity and therapeutic inhibition. Biochem Soc Trans. 2002;30:552–557. [PubMed]
  • Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, et al. Alzheimer's disease-affected brain: Presence of oligomeric a beta ligands (addls) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A. 2003;100:10417–10422. doi: 10.1073/pnas.1834302100. Available: http://dx.doi.org/10.1073/pnas.1834302100. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2005;8:79–84. doi: 10.1038/nn1372. Available: http://dx.doi.org/10.1038/nn1372. Accessed 8 August 2007. [PubMed]
  • Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8:101–112. doi: 10.1038/nrm2101. Available: http://dx.doi.org/10.1038/nrm2101. Accessed 8 August 2007. [PubMed]
  • Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002;416:507–511. doi: 10.1038/416507a. Available: http://dx.doi.org/10.1038/416507a. Accessed 8 August 2007. [PubMed]
  • Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486–489. doi: 10.1126/science.1079469. Available: http://dx.doi.org/10.1126/science.1079469. Accessed 8 August 2007. [PubMed]
  • Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, et al. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem. 2004;279:31374–31382. doi: 10.1074/jbc.M400348200. Available: http://dx.doi.org/10.1074/jbc.M400348200. Accessed 8 August 2007. [PubMed]
  • Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. The most infectious prion protein particles. Nature. 2005;437:257–261. doi: 10.1038/nature03989. Available: http://dx.doi.org/10.1038/nature03989. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, et al. Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci. 2006;26:8160–8167. doi: 10.1523/JNEUROSCI.4809–05.2006. Available: http://dx.doi.org/10.1523/JNEUROSCI.4809–05.2006. Accessed 8 August 2007. [PubMed]
  • Oh D, Shin SY, Lee S, Kang JH, Kim SD, et al. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin a(1–8)-magainin 2(1–12), and its analogues, on their antibiotic activities and structures. Biochemistry. 2000;39:11855–11864. [PubMed]
  • Oma Y, Kino Y, Sasagawa N, Ishiura S. Comparative analysis of the cytotoxicity of homopolymeric amino acids. Biochim Biophys Acta. 2005;1748:174–179. doi: 10.1016/j.bbapap.2004.12.017. Available: http://dx.doi.org/10.1016/j.bbapap.2004.12.017. Accessed 8 August 2007. [PubMed]
  • Ferre R, Badosa E, Feliu L, Planas M, Montesinos E, et al. Inhibition of plant-pathogenic bacteria by short synthetic cecropin a-melittin hybrid peptides. Appl Environ Microbiol. 2006;72:3302–3308. doi: 10.1128/AEM.72.5.3302–3308.2006. http://dx.doi.org/10.1128/AEM.72.5.3302–3308.2006. Accessed 13 August 2007. [PMC free article] [PubMed]
  • Plakoutsi G, Bemporad F, Calamai M, Taddei N, Dobson CM, et al. Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol. 2005;351:910–922. doi: 10.1016/j.jmb.2005.06.043. Available: http://dx.doi.org/10.1016/j.jmb.2005.06.043. Accessed 8 August 2007. [PubMed]
  • Petty SA, Decatur SM. Experimental evidence for the reorganization of beta-strands within aggregates of the Abeta(16–22) peptide. J Am Chem Soc. 2005;127:13488–13489. doi: 10.1021/ja054663y. Available: http://dx.doi.org/10.1021/ja054663y. Accessed 8 August 2007. [PubMed]
  • Cerdà-Costa N, Esteras-Chopo A, Avilés FX, Serrano L, Villegas V. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J Mol Biol. 2007;366:1351–1363. doi: 10.1016/j.jmb.2006.12.007. http://dx.doi.org/10.1016/j.jmb.2006.12.007. Accessed 8 August 2007. [PubMed]
  • Pellarin R, Caflisch A. Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol. 2006;360:882–892. doi: 10.1016/j.jmb.2006.05.033. Available: http://dx.doi.org/10.1016/j.jmb.2006.05.033. Accessed 8 August 2007. [PubMed]
  • Klimov DK, Thirumalai D. Dissecting the assembly of Abeta16–22 amyloid peptides into antiparallel beta sheets. Structure. 2003;11:295–307. [PubMed]
  • Nguyen PH, Li MS, Stock G, Straub JE, Thirumalai D. Monomer adds to preformed structured oligomers of Abeta-peptides by a two-stage dock-lock mechanism. Proc Natl Acad Sci U S A. 2007;104:111–116. doi: 10.1073/pnas.0607440104. Available: http://dx.doi.org/10.1073/pnas.0607440104. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, et al. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry. 2000;39:6288–6295. [PubMed]
  • Thirumalai D, Klimov DK, Dima RI. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol. 2003;13:146–159. [PubMed]
  • Nguyen HD, Hall CK. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci U S A. 2004;101:16180–16185. doi: 10.1073/pnas.0407273101. Available: http://dx.doi.org/10.1073/pnas.0407273101. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Hwang W, Zhang S, Kamm RD, Karplus M. Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci U S A. 2004;101:12916–12921. doi: 10.1073/pnas.0402634101. Available: http://dx.doi.org/10.1073/pnas.0402634101. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Buchete NV, Tycko R, Hummer G. Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. J Mol Biol. 2005;353:804–821. doi: 10.1016/j.jmb.2005.08.066. Available: http://dx.doi.org/10.1016/j.jmb.2005.08.066. Accessed 8 August 2007. [PubMed]
  • de la Paz ML, de Mori GMS, Serrano L, Colombo G. Sequence dependence of amyloid fibril formation: Insights from molecular dynamics simulations. J Mol Biol. 2005;349:583–596. doi: 10.1016/j.jmb.2005.03.081. http://dx.doi.org/10.1016/j.jmb.2005.03.081. Accessed 13 August 2007. [PubMed]
  • Khare SD, Ding F, Gwanmesia KN, Dokholyan NV. Molecular origin of polyglutamine aggregation in neurodegenerative diseases. PLoS Comput Biol. 2005;1:230–235. doi: 10.1371/journal.pcbi.0010030.. http://dx.doi.org/10.1371/journal.pcbi.0010030. Accessed 13 August 2007. [PMC free article] [PubMed]
  • Hoang TX, Marsella L, Trovato A, Seno F, Banavar JR, et al. Common attributes of native-state structures of proteins, disordered proteins, and amyloid. Proc Natl Acad Sci U S A. 2006;103:6883–6888. doi: 10.1073/pnas.0601824103. Available: http://dx.doi.org/10.1073/pnas.0601824103. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Ma B, Nussinov R. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr Opin Chem Biol. 2006;10:445–452. doi: 10.1016/j.cbpa.2006.08.018. Available: http://dx.doi.org/10.1016/j.cbpa.2006.08.018. Accessed 8 August 2007. [PubMed]
  • Teplow DB, Lazo ND, Bitan G, Bernstein S, Wyttenbach T, et al. Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. Acc Chem Res. 2006;39:635–645. doi: 10.1021/ar050063s. Available: http://dx.doi.org/10.1021/ar050063s. Accessed 8 August 2007. [PubMed]
  • Boucher G, Mousseau N, Derreumaux P. Aggregating the amyloid Abeta(11–25) peptide into a four-stranded beta-sheet structure. Proteins. 2006;65:877–888. doi: 10.1002/prot.21134. http://dx.doi.org/10.1002/prot.21134. Accessed 13 August 2007. [PubMed]
  • Santini S, Mousseau N, Derreumaux P. In silico assembly of Alzheimer's Abeta16–22 peptide into beta-sheets. J Am Chem Soc. 2004;126:11509–11516. doi: 10.1021/ja047286i. Available: http://dx.doi.org/10.1021/ja047286i. Accessed 8 August 2007. [PubMed]
  • Urbanc B, Cruz L, Ding F, Sammond D, Khare S, et al. Molecular dynamics simulation of amyloid beta dimer formation. Biophys J. 2004;87:2310–2321. doi: 10.1529/biophysj.104.040980. Available: http://dx.doi.org/10.1529/biophysj.104.040980. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Irbäck A, Samuelsson B, Sjunnesson F, Wallin S. Thermodynamics of alpha- and beta-structure formation in proteins. Biophys J. 2003;85:1466–1473. [PMC free article] [PubMed]
  • Favrin G, Irbäck A, Mohanty S. Oligomerization of amyloid Abeta16–22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J. 2004;87:3657–3664. doi: 10.1529/biophysj.104.046839. Available: http://dx.doi.org/10.1529/biophysj.104.046839. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Irbäck A, Sjunnesson F. Folding thermodynamics of three beta-sheet peptides: A model study. Proteins. 2004;56:110–116. doi: 10.1002/prot.20157. Available: http://dx.doi.org/10.1002/prot.20157. Accessed 8 August 2007. [PubMed]
  • Irbäck A, Mohanty S. Folding thermodynamics of peptides. Biophys J. 2005;88:1560–1569. doi: 10.1529/biophysj.104.050427. http://dx.doi.org/10.1529/biophysj.104.050427. Accessed 13 August 2007. [PMC free article] [PubMed]
  • Irbäck A, Mohanty S. Profasi: A monte carlo simulation package for protein folding and aggregation. J Comput Chem. 2006;27:1548–1555. doi: 10.1002/jcc.20452. Available: http://dx.doi.org/10.1002/jcc.20452. Accessed 8 August 2007. [PubMed]
  • Liao MQ, Tzeng YJ, Chang LYX, Huang HB, Lin TH, et al. The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett. 2007;581:1161–1165. doi: 10.1016/j.febslet.2007.02.026. [PubMed]
  • Lashuel HA, Lansbury PT. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys. 2006;39:167–201. doi: 10.1017/S0033583506004422. Available: http://dx.doi.org/10.1017/S0033583506004422. Accessed 8 August 2007. [PubMed]
  • Milojevic J, Esposito V, Das R, Melacini G. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation nmr spectroscopy. J Am Chem Soc. 2007. 10.1021/ja067367+. http://dx.doi.org/10.1021/ja067367+. [PubMed]
  • Carrotta R, Bauer R, Waninge R, Rischel C. Conformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregation. Protein Sci. 2001;10:1312–1318. [PMC free article] [PubMed]
  • Kuwahara H, Yamasaki T, Hatakeyama T, Aoyagi H, Fujisawa T. Oligomerization process of the hemolytic lectin cel-iii purified from a sea cucumber, cucumaria echinata. J Biochem (Tokyo) 2002;131:751–756. [PubMed]
  • Calamai M, Chiti F, Dobson CM. Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J. 2005;89:4201–4210. doi: 10.1529/biophysj.105.068726. Available: http://dx.doi.org/10.1529/biophysj.105.068726. Accessed 8 August 2007. [PMC free article] [PubMed]
  • Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, et al. Amyloid fibril formation by a beta 16–22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state nmr. Biochemistry. 2000;39:13748–13759. [PubMed]
  • Favrin G, Irbäck A, Sjunnesson F. Monte carlo update for chain molecules: Biased gaussian steps in torsional space. J Chem Phys. 2001;114:8154–8158.
  • Shimada J, Kussell EL, Shakhnovich EI. The folding thermodynamics and kinetics of crambin using an all-atom monte carlo simulation. J Mol Biol. 2001;308:79–95. doi: 10.1006/jmbi.2001.4586. Available: http://dx.doi.org/10.1006/jmbi.2001.4586. Accessed 8 August 2007. [PubMed]
  • ten Wolde PR, Ruiz-Montero, Frenkel D. Numerical evidence for bcc ordering at the surface of a critical fcc nucleus. Phys Rev Lett. 1995;75:2714–2717. [PubMed]
  • Auer S, Frenkel D. Quantitative prediction of crystal-nucleation rates for spherical colloids: A computational approach. Annu Rev Phys Chem. 2004;55:333–361. doi: 10.1146/annurev.physchem.55.091602.094402. Available: http://dx.doi.org/10.1146/annurev.physchem.55.091602.094402. Accessed 8 August 2007. [PubMed]

Articles from PLoS Computational Biology are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Links

  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...